MedPath
HSA Approval

EZETIMIBE SANDOZ TABLET 10MG

SIN15179P

EZETIMIBE SANDOZ TABLET 10MG

EZETIMIBE SANDOZ TABLET 10MG

February 23, 2017

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

TABLET

ORAL

Medical Information

C10AX09

ezetimibe

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Lek Pharmaceuticals, d.d.

Lek Pharmaceuticals d.d. (Lendava) (Primary and Secondary packager)

Active Ingredients

Ezetimibe

10mg

Ezetimibe

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EZETIMIBE SANDOZ TABLET 10MG - HSA Approval | MedPath